(I don't pretend to have enough insight, being a newbie to the stock to have any worthwhile contribution howver, as a newbie I appreciate the information and insight you bring to the forum.
It seems to be stuck in a hole at the moment. I had envisaged that by now it would have been able to define its immediate future course, announce it and get on with it. Its deal with Amron doesn't seem to have excited the market as much as I had hoped.
"a company on the cusp of potential domination of a healthcare diagnostic segment that has similarities to the ascent of ResMed in its particular market" is a pretty glowing endorsement but it doesn't matter what is written if it doesn't get up and go. Is it suffering from the unknown quantity syndrome??
KSX Price at posting:
1.4¢ Sentiment: Hold Disclosure: Held